Learn More
Medchemexpress LLC PKSI-527 hydrochloride | 128837-71-8 | MFCD01745772 | 98.1% | 473.99 g·mol⁻¹ | C25H32ClN3O4 | 50MG

Supplier: Medchemexpress LLC HY12313350MG
PKSI-527 is a selective small-molecule plasma kallikrein inhibitor used in preclinical research to investigate the kallikrein-kinin pathway and inflammatory disease models such as collagen-induced arthritis. It is supplied as a characterized hydrochloride salt at high purity for laboratory use only and is intended for in vitro and in vivo research under appropriate approvals.
- Highly selective plasma kallikrein inhibition.
- Applicable to preclinical models of inflammatory disease.
- Suitable for in vitro enzyme and cellular assays.
- Appropriate for in vivo disease-model investigations.
- Supplied at high purity for reproducible results.
- Characterized by molecular formula and molecular weight.
- Provided as a hydrochloride salt for stability and handling.
- Intended for research use only; not for human consumption.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.